GITNUXREPORT 2025

Digital Transformation In The Pharmaceutical Industry Statistics

Most pharma firms invest heavily in digital tech to enhance innovation and efficiency.

Jannik Linder

Co-Founder of Gitnux, specialized in content and tech since 2016.

First published: April 29, 2025

Our Commitment to Accuracy

Rigorous fact-checking • Reputable sources • Regular updatesLearn more

Statistic 1

70% of pharmaceutical companies have increased their investment in digital transformation initiatives between 2020 and 2022

Statistic 2

The pharmaceutical industry is projected to spend over $20 billion on digital technology by 2025

Statistic 3

Around 68% of pharmaceutical firms utilize big data analytics to optimize R&D and marketing strategies

Statistic 4

Cloud computing adoption in pharma increased by 45% from 2019 to 2022

Statistic 5

75% of pharma companies are investing in digital talent development and reskilling programs

Statistic 6

Digital sterile manufacturing technologies are expected to reduce operational costs by up to 25%

Statistic 7

65% of clinical trial data is now collected through digital means, including wearable devices and mobile apps

Statistic 8

The global digital therapeutics market in pharma is expected to reach $9 billion by 2027, growing at a CAGR of 27%

Statistic 9

60% of pharma companies plan to increase their investments in digital capabilities in the next two years

Statistic 10

Digital pathology is used in 70% of pharmaceutical R&D for faster and more accurate analysis

Statistic 11

Investment in cybersecurity measures in pharma increased by 35% from 2021 to 2023

Statistic 12

The global investment in digital health startups focused on pharma solutions reached $9 billion in 2022, doubling since 2020

Statistic 13

38% of pharma R&D budgets are now allocated to digital innovations, up from 20% in 2019

Statistic 14

Digital therapeutics are projected to grow at a CAGR of 27%, reaching over $9 billion globally by 2027

Statistic 15

72% of global pharma organizations have a dedicated digital transformation team or leadership role

Statistic 16

The global digital health market revenue is forecasted to reach $660 billion by 2025, driven largely by pharma digital transformation

Statistic 17

55% of pharma firms are exploring digital solutions for supply chain sustainability and reducing environmental impact

Statistic 18

The global digital therapeutics revenue is reaching an estimated $1.2 billion in 2023 and is expected to grow rapidly in the coming years

Statistic 19

The average digital transformation spending per pharma company increased by 25% from 2020 to 2022, reaching over $5 million

Statistic 20

AI and machine learning are used by 65% of pharmaceutical companies to accelerate drug discovery processes

Statistic 21

40% of pharma organizations utilize blockchain technology for supply chain security and transparency

Statistic 22

Machine learning algorithms have improved the accuracy of adverse event prediction in clinical trials by 40%

Statistic 23

63% of healthcare providers working with pharma companies use digital analytics to inform their treatment decisions

Statistic 24

The use of real-world evidence in regulatory submissions increased by 67% from 2019 to 2023

Statistic 25

80% of pharma R&D organizations utilize AI-driven data analysis for target identification

Statistic 26

73% of pharma companies plan to partner with technology firms to accelerate digital innovation

Statistic 27

The use of predictive analytics in pharma manufacturing resulted in a 20% decrease in quality deviations

Statistic 28

The adoption of data lakes in pharma has grown by 45% over the past three years to centralize large datasets

Statistic 29

The use of 3D printing for personalized drug delivery increased by 30% between 2020 and 2023

Statistic 30

65% of pharma companies plan to collaborate more with tech startups to accelerate digital innovation

Statistic 31

The use of automated data extraction for regulatory submission increased by 50% in the past three years

Statistic 32

Investment in digital health technologies for orphan diseases increased by 40% over the past two years

Statistic 33

The utilization of 5G technology in pharma manufacturing and supply chain increased by 35% from 2020 to 2023, enhancing connectivity and data transfer

Statistic 34

73% of pharma data scientists report that AI accelerates the discovery of novel drug candidates

Statistic 35

Digital health startups focusing on pharma reached $9 billion in investment funding in 2022, doubling the amount from 2020

Statistic 36

The global market for digital biomarkers in pharma is projected to reach $3.5 billion by 2026, growing at a CAGR of 31%

Statistic 37

The adoption of AI for medical image analysis in pharma R&D grew by 60% from 2020 to 2023, improving diagnostic accuracy

Statistic 38

The number of digital health patents filed by pharma companies increased by 30% in 2022 compared to 2020, indicating growing innovation activity

Statistic 39

60% of pharma firms have implemented digital twins for clinical trials

Statistic 40

52% of pharmaceutical companies report increased efficiency after adopting digital supply chain solutions

Statistic 41

48% of pharma companies have integrated electronic health records (EHRs) to streamline data sharing

Statistic 42

Digital marketing spend in the pharmaceutical industry reached approximately $3.5 billion in 2022, rising from $2 billion in 2019

Statistic 43

Mobile health apps are used by 55% of pharma companies for remote patient monitoring and engagement

Statistic 44

Digital transformation has shortened drug development timelines by an average of 15-20%

Statistic 45

Usage of virtual reality (VR) and augmented reality (AR) for training purposes increased by 70% in pharma environments since 2020

Statistic 46

55% of pharma companies are using chatbots for customer service and pre-screening

Statistic 47

Digital workflows in clinical trials increased trial enrollment rates by 30% on average

Statistic 48

The integration of IoT devices in pharmaceutical manufacturing increased by 50% between 2020 and 2022

Statistic 49

Digital supply chain visibility solutions have improved pharmaceutical inventory accuracy by 25-30%

Statistic 50

45% of clinical trials incorporated adaptive design models enabled by digital tools in 2023

Statistic 51

Digital patient adherence systems have increased medication compliance rates by approximately 15%

Statistic 52

Virtual clinical trials led to a 20% reduction in patient dropout rates compared to traditional trials

Statistic 53

Digital content marketing in pharma increased by 60% from 2019 to 2022, reaching an estimated $500 million annually

Statistic 54

54% of pharma organizations are exploring or implementing augmented reality tools for patient education

Statistic 55

Virtual assistants in pharma customer service handled over 30 million inquiries in 2022 alone

Statistic 56

59% of global pharma companies have adopted digital tools for pharmacovigilance activities

Statistic 57

Digital health literacy programs have trained over 10,000 healthcare professionals globally since 2020

Statistic 58

48% of pharma companies utilize robotics process automation (RPA) to streamline administrative tasks

Statistic 59

52% of clinical data is now collected through mobile devices, enabling more flexible trial designs

Statistic 60

65% of pharma companies use digital tools for patient recruitment and retention in clinical trials

Statistic 61

Digital platforms for physician engagement grew by 40% in use among pharma companies from 2019 to 2022

Statistic 62

80% of pharma companies reported a reduction in time-to-market after implementing digital R&D tools

Statistic 63

Digital transformation initiatives led to an average increase of 22% in sales revenue among pharma companies in 2023

Statistic 64

Over 60% of pharma companies are integrating wearable devices into their R&D and patient programs

Statistic 65

55% of pharmaceuticals companies have adopted digital onboarding processes for new employees, improving onboarding efficiency by 35%

Statistic 66

The number of pharma companies with fully integrated digital supply chains increased by 50% in the past two years

Statistic 67

77% of pharmaceutical organizations utilize digital health records for clinical data management

Statistic 68

85% of clinical trial sites now use digital platforms for patient monitoring

Statistic 69

The adoption of digital manufacturing processes in pharma increased by 65% from 2020 to 2022

Statistic 70

Digital patient portals are used by 70% of pharma companies to enhance patient communication and data collection

Statistic 71

The use of digital endpoint monitoring in clinical trials rose by 60% from 2019 to 2023

Statistic 72

45% of pharma companies now use artificial intelligence for pharmacovigilance and safety surveillance

Statistic 73

Digital supply chain traceability solutions have reduced counterfeit drug circulation by 40%

Statistic 74

30% of pharma firms are piloting or using digital sensor technology to monitor manufacturing conditions in real-time

Statistic 75

Over 40% of pharmaceutical companies conduct digital maturity assessments annually to guide strategy

Statistic 76

Adoption of real-time analytics in pharma production increased by 55% since 2020, improving decision-making speed

Statistic 77

The implementation of virtual trial platforms has saved an average of $50 million per trial

Statistic 78

69% of pharma brands now include digital campaign elements as part of their overall marketing strategy

Statistic 79

80% of pharmaceutical manufacturing sites plan to upgrade to digital control systems within the next five years

Statistic 80

50% of pharma companies now use digital tools for employee onboarding and training, leading to faster integration

Statistic 81

Digital QR codes for product authentication and tracking are used in 65% of pharmaceutical packaging, preventing counterfeit access

Statistic 82

Digital therapy adherence programs have improved medication adherence rates by 12% on average across multiple studies

Statistic 83

60% of pharma companies are actively exploring or implementing AI-driven predictive maintenance for manufacturing equipment

Statistic 84

62% of pharmaceutical companies have adopted or plan to adopt virtual reality environments for employee training by 2024

Statistic 85

The implementation of digital analytics tools in pharma R&D increased drug discovery success rates by 15%

Statistic 86

55% of pharma companies utilize digital platforms for post-market surveillance to monitor drug safety

Statistic 87

Over 80% of pharma companies have developed or are developing digital health companion apps for patients, improving adherence and outcomes

Statistic 88

Digital automation in clinical data management reduced processing times by 35% between 2020 and 2023

Statistic 89

The use of cloud-based collaborative platforms in pharma increased by 50% from 2021 to 2023, facilitating multi-institutional studies

Statistic 90

65% of global pharma companies are investing in digital ethics and compliance tools to ensure responsible innovation

Statistic 91

The adoption rate of electronic prescribing systems in pharma-related healthcare increased to 90% in hospitals worldwide by 2023

Statistic 92

70% of pharma companies implement AI-driven customer segmentation for targeted marketing, increasing campaign ROI by 25%

Statistic 93

44% of pharmaceutical companies have integrated digital authentication tools into their packaging to combat counterfeiting

Statistic 94

80% of clinical trial sites now leverage digital platforms for remote monitoring, reducing trial costs and time

Statistic 95

The deployment of digital case report forms (eCRFs) in clinical trials increased by 55% between 2020 and 2023, improving data quality

Statistic 96

The use of digital tools for medication adherence monitoring increased by 20% in 2022, leading to improved patient outcomes

Statistic 97

67% of pharmaceutical companies are now employing digital simulation and modeling to predict clinical trial outcomes

Statistic 98

Digital transformation has enabled pharma companies to reduce distribution lead times by an average of 22%, ensuring faster delivery of medicines

Statistic 99

83% of pharma companies are investing in digital tools to improve clinical data integrity and security

Statistic 100

The integration of digital health monitoring devices in clinical trials increased by 50% between 2020 and 2023, leading to richer data collection

Statistic 101

45% of pharma companies utilize digital tools for regulatory compliance documentation, reducing audit preparation time by 30%

Statistic 102

66% of pharma companies employ digital storytelling and content marketing strategies to educate patients and healthcare providers

Statistic 103

75% of pharma firms are integrating digital health solutions into their product portfolios, expanding their digital offerings

Statistic 104

The use of digital patient feedback tools in pharma increased by 50% from 2020 to 2023, aiding in real-time product improvement

Statistic 105

80% of clinical trial data are now stored and managed in cloud-based systems, enhancing collaboration and data security

Statistic 106

85% of pharma executives believe that digital transformation significantly impacts their company's growth

Statistic 107

80% of pharmaceutical companies consider cybersecurity a top priority in digital transformation efforts

Statistic 108

82% of pharma firms see digital health data as critical to personalized medicine development

Statistic 109

78% of pharma executives believe digital transformation will be essential to future competitive advantage

Statistic 110

66% of pharmaceutical firms see a positive ROI from digital transformation investments within three years

Statistic 111

Nearly 60% of pharma companies report that digital initiatives have improved compliance with regulatory standards

Statistic 112

83% of pharma R&D leaders see cloud computing as essential for scalability and data sharing

Statistic 113

87% of pharma companies agree that integrating digital health records improves patient safety

Statistic 114

88% of pharma executives believe that digital transformation is essential for responding to future health crises

Statistic 115

91% of pharma companies agree that digital transformation enhances innovation capacity

Statistic 116

78% of global pharma companies plan to invest more heavily in digital talent acquisition and development over the next two years

Statistic 117

Patient engagement platforms have been adopted by 75% of global pharma companies to improve communication and compliance

Statistic 118

Digital patient engagement tools have increased patient recruitment for clinical trials by 25%

Slide 1 of 118

Sources

Our Reports have been cited by:

Trust Badges - Publications that have cited our reports

Key Highlights

70% of pharmaceutical companies have increased their investment in digital transformation initiatives between 2020 and 2022
The pharmaceutical industry is projected to spend over $20 billion on digital technology by 2025
85% of pharma executives believe that digital transformation significantly impacts their company's growth
AI and machine learning are used by 65% of pharmaceutical companies to accelerate drug discovery processes
60% of pharma firms have implemented digital twins for clinical trials
52% of pharmaceutical companies report increased efficiency after adopting digital supply chain solutions
Patient engagement platforms have been adopted by 75% of global pharma companies to improve communication and compliance
Around 68% of pharmaceutical firms utilize big data analytics to optimize R&D and marketing strategies
Cloud computing adoption in pharma increased by 45% from 2019 to 2022
48% of pharma companies have integrated electronic health records (EHRs) to streamline data sharing
Digital marketing spend in the pharmaceutical industry reached approximately $3.5 billion in 2022, rising from $2 billion in 2019
80% of pharmaceutical companies consider cybersecurity a top priority in digital transformation efforts
Mobile health apps are used by 55% of pharma companies for remote patient monitoring and engagement

Digital transformation is revolutionizing the pharmaceutical industry, with over 70% of companies increasing investments and projected spending surpassing $20 billion by 2025, showcasing how embracing digital tools—from AI-driven drug discovery to digital supply chains—is accelerating innovation, improving patient outcomes, and securing a competitive edge in a rapidly evolving healthcare landscape.

Digital Transformation Adoption and Spending

70% of pharmaceutical companies have increased their investment in digital transformation initiatives between 2020 and 2022
The pharmaceutical industry is projected to spend over $20 billion on digital technology by 2025
Around 68% of pharmaceutical firms utilize big data analytics to optimize R&D and marketing strategies
Cloud computing adoption in pharma increased by 45% from 2019 to 2022
75% of pharma companies are investing in digital talent development and reskilling programs
Digital sterile manufacturing technologies are expected to reduce operational costs by up to 25%
65% of clinical trial data is now collected through digital means, including wearable devices and mobile apps
The global digital therapeutics market in pharma is expected to reach $9 billion by 2027, growing at a CAGR of 27%
60% of pharma companies plan to increase their investments in digital capabilities in the next two years
Digital pathology is used in 70% of pharmaceutical R&D for faster and more accurate analysis
Investment in cybersecurity measures in pharma increased by 35% from 2021 to 2023
The global investment in digital health startups focused on pharma solutions reached $9 billion in 2022, doubling since 2020
38% of pharma R&D budgets are now allocated to digital innovations, up from 20% in 2019
Digital therapeutics are projected to grow at a CAGR of 27%, reaching over $9 billion globally by 2027
72% of global pharma organizations have a dedicated digital transformation team or leadership role
The global digital health market revenue is forecasted to reach $660 billion by 2025, driven largely by pharma digital transformation
55% of pharma firms are exploring digital solutions for supply chain sustainability and reducing environmental impact
The global digital therapeutics revenue is reaching an estimated $1.2 billion in 2023 and is expected to grow rapidly in the coming years
The average digital transformation spending per pharma company increased by 25% from 2020 to 2022, reaching over $5 million

Digital Transformation Adoption and Spending Interpretation

With over 70% of pharmaceutical companies boosting digital investments—spending over $20 billion by 2025, embracing big data, cloud tech, and digital therapeutics—it's clear that the industry is not just seeking to cure diseases but also to digitally cure inefficiencies, making medicine smarter, faster, and more sustainable—even as cybersecurity spending and talent reskilling become part of the script.

Emerging Technologies and Data Utilization

AI and machine learning are used by 65% of pharmaceutical companies to accelerate drug discovery processes
40% of pharma organizations utilize blockchain technology for supply chain security and transparency
Machine learning algorithms have improved the accuracy of adverse event prediction in clinical trials by 40%
63% of healthcare providers working with pharma companies use digital analytics to inform their treatment decisions
The use of real-world evidence in regulatory submissions increased by 67% from 2019 to 2023
80% of pharma R&D organizations utilize AI-driven data analysis for target identification
73% of pharma companies plan to partner with technology firms to accelerate digital innovation
The use of predictive analytics in pharma manufacturing resulted in a 20% decrease in quality deviations
The adoption of data lakes in pharma has grown by 45% over the past three years to centralize large datasets
The use of 3D printing for personalized drug delivery increased by 30% between 2020 and 2023
65% of pharma companies plan to collaborate more with tech startups to accelerate digital innovation
The use of automated data extraction for regulatory submission increased by 50% in the past three years
Investment in digital health technologies for orphan diseases increased by 40% over the past two years
The utilization of 5G technology in pharma manufacturing and supply chain increased by 35% from 2020 to 2023, enhancing connectivity and data transfer
73% of pharma data scientists report that AI accelerates the discovery of novel drug candidates
Digital health startups focusing on pharma reached $9 billion in investment funding in 2022, doubling the amount from 2020
The global market for digital biomarkers in pharma is projected to reach $3.5 billion by 2026, growing at a CAGR of 31%
The adoption of AI for medical image analysis in pharma R&D grew by 60% from 2020 to 2023, improving diagnostic accuracy
The number of digital health patents filed by pharma companies increased by 30% in 2022 compared to 2020, indicating growing innovation activity

Emerging Technologies and Data Utilization Interpretation

Despite the rapid surge in digital tools—from AI-powered drug discovery to blockchain-secured supply chains—pharma’s true breakthrough lies in transforming data into cures, proving that whether through 3D printing or predictive analytics, they’re finally treating digital innovation as their most potent prescription.

Implementation of Digital Strategies and Tools

60% of pharma firms have implemented digital twins for clinical trials
52% of pharmaceutical companies report increased efficiency after adopting digital supply chain solutions
48% of pharma companies have integrated electronic health records (EHRs) to streamline data sharing
Digital marketing spend in the pharmaceutical industry reached approximately $3.5 billion in 2022, rising from $2 billion in 2019
Mobile health apps are used by 55% of pharma companies for remote patient monitoring and engagement
Digital transformation has shortened drug development timelines by an average of 15-20%
Usage of virtual reality (VR) and augmented reality (AR) for training purposes increased by 70% in pharma environments since 2020
55% of pharma companies are using chatbots for customer service and pre-screening
Digital workflows in clinical trials increased trial enrollment rates by 30% on average
The integration of IoT devices in pharmaceutical manufacturing increased by 50% between 2020 and 2022
Digital supply chain visibility solutions have improved pharmaceutical inventory accuracy by 25-30%
45% of clinical trials incorporated adaptive design models enabled by digital tools in 2023
Digital patient adherence systems have increased medication compliance rates by approximately 15%
Virtual clinical trials led to a 20% reduction in patient dropout rates compared to traditional trials
Digital content marketing in pharma increased by 60% from 2019 to 2022, reaching an estimated $500 million annually
54% of pharma organizations are exploring or implementing augmented reality tools for patient education
Virtual assistants in pharma customer service handled over 30 million inquiries in 2022 alone
59% of global pharma companies have adopted digital tools for pharmacovigilance activities
Digital health literacy programs have trained over 10,000 healthcare professionals globally since 2020
48% of pharma companies utilize robotics process automation (RPA) to streamline administrative tasks
52% of clinical data is now collected through mobile devices, enabling more flexible trial designs
65% of pharma companies use digital tools for patient recruitment and retention in clinical trials
Digital platforms for physician engagement grew by 40% in use among pharma companies from 2019 to 2022
80% of pharma companies reported a reduction in time-to-market after implementing digital R&D tools
Digital transformation initiatives led to an average increase of 22% in sales revenue among pharma companies in 2023
Over 60% of pharma companies are integrating wearable devices into their R&D and patient programs
55% of pharmaceuticals companies have adopted digital onboarding processes for new employees, improving onboarding efficiency by 35%
The number of pharma companies with fully integrated digital supply chains increased by 50% in the past two years
77% of pharmaceutical organizations utilize digital health records for clinical data management
85% of clinical trial sites now use digital platforms for patient monitoring
The adoption of digital manufacturing processes in pharma increased by 65% from 2020 to 2022
Digital patient portals are used by 70% of pharma companies to enhance patient communication and data collection
The use of digital endpoint monitoring in clinical trials rose by 60% from 2019 to 2023
45% of pharma companies now use artificial intelligence for pharmacovigilance and safety surveillance
Digital supply chain traceability solutions have reduced counterfeit drug circulation by 40%
30% of pharma firms are piloting or using digital sensor technology to monitor manufacturing conditions in real-time
Over 40% of pharmaceutical companies conduct digital maturity assessments annually to guide strategy
Adoption of real-time analytics in pharma production increased by 55% since 2020, improving decision-making speed
The implementation of virtual trial platforms has saved an average of $50 million per trial
69% of pharma brands now include digital campaign elements as part of their overall marketing strategy
80% of pharmaceutical manufacturing sites plan to upgrade to digital control systems within the next five years
50% of pharma companies now use digital tools for employee onboarding and training, leading to faster integration
Digital QR codes for product authentication and tracking are used in 65% of pharmaceutical packaging, preventing counterfeit access
Digital therapy adherence programs have improved medication adherence rates by 12% on average across multiple studies
60% of pharma companies are actively exploring or implementing AI-driven predictive maintenance for manufacturing equipment
62% of pharmaceutical companies have adopted or plan to adopt virtual reality environments for employee training by 2024
The implementation of digital analytics tools in pharma R&D increased drug discovery success rates by 15%
55% of pharma companies utilize digital platforms for post-market surveillance to monitor drug safety
Over 80% of pharma companies have developed or are developing digital health companion apps for patients, improving adherence and outcomes
Digital automation in clinical data management reduced processing times by 35% between 2020 and 2023
The use of cloud-based collaborative platforms in pharma increased by 50% from 2021 to 2023, facilitating multi-institutional studies
65% of global pharma companies are investing in digital ethics and compliance tools to ensure responsible innovation
The adoption rate of electronic prescribing systems in pharma-related healthcare increased to 90% in hospitals worldwide by 2023
70% of pharma companies implement AI-driven customer segmentation for targeted marketing, increasing campaign ROI by 25%
44% of pharmaceutical companies have integrated digital authentication tools into their packaging to combat counterfeiting
80% of clinical trial sites now leverage digital platforms for remote monitoring, reducing trial costs and time
The deployment of digital case report forms (eCRFs) in clinical trials increased by 55% between 2020 and 2023, improving data quality
The use of digital tools for medication adherence monitoring increased by 20% in 2022, leading to improved patient outcomes
67% of pharmaceutical companies are now employing digital simulation and modeling to predict clinical trial outcomes
Digital transformation has enabled pharma companies to reduce distribution lead times by an average of 22%, ensuring faster delivery of medicines
83% of pharma companies are investing in digital tools to improve clinical data integrity and security
The integration of digital health monitoring devices in clinical trials increased by 50% between 2020 and 2023, leading to richer data collection
45% of pharma companies utilize digital tools for regulatory compliance documentation, reducing audit preparation time by 30%
66% of pharma companies employ digital storytelling and content marketing strategies to educate patients and healthcare providers
75% of pharma firms are integrating digital health solutions into their product portfolios, expanding their digital offerings
The use of digital patient feedback tools in pharma increased by 50% from 2020 to 2023, aiding in real-time product improvement
80% of clinical trial data are now stored and managed in cloud-based systems, enhancing collaboration and data security

Implementation of Digital Strategies and Tools Interpretation

The pharmaceutical industry’s digital ramp-up—from virtual trials and AI-powered safety to digital supply chains and patient engagement—not only accelerates drug development and enhances safety but also transforms the corporate landscape into a fast-paced, tech-driven frontier where data rules, counterfeit defenses are strengthened, and patient outcomes are more connected than ever.

Industry Opinions and Attitudes

85% of pharma executives believe that digital transformation significantly impacts their company's growth
80% of pharmaceutical companies consider cybersecurity a top priority in digital transformation efforts
82% of pharma firms see digital health data as critical to personalized medicine development
78% of pharma executives believe digital transformation will be essential to future competitive advantage
66% of pharmaceutical firms see a positive ROI from digital transformation investments within three years
Nearly 60% of pharma companies report that digital initiatives have improved compliance with regulatory standards
83% of pharma R&D leaders see cloud computing as essential for scalability and data sharing
87% of pharma companies agree that integrating digital health records improves patient safety
88% of pharma executives believe that digital transformation is essential for responding to future health crises
91% of pharma companies agree that digital transformation enhances innovation capacity
78% of global pharma companies plan to invest more heavily in digital talent acquisition and development over the next two years

Industry Opinions and Attitudes Interpretation

In an industry where a majority see digital transformation as key to growth, innovation, and resilience, pharma executives are not just embracing the future—they're investing heavily in the digital revolution to stay ahead of the curve and safeguard both patient safety and their bottom line.

Patient Engagement and Feedback Technologies

Patient engagement platforms have been adopted by 75% of global pharma companies to improve communication and compliance
Digital patient engagement tools have increased patient recruitment for clinical trials by 25%

Patient Engagement and Feedback Technologies Interpretation

With three-quarters of pharma firms adopting digital engagement tools—boosting trial recruitment by a quarter—the industry is clearly prescribing tech-savvy communication as the new medicine for better patient outcomes and compliance.